Clinical Trial Update: Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update from King Saud University describes evaluating the effects of first-line oral hypoglycemic agents on bone turnover markers in tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Type 2 Diabetes Mellitus

Snippet

Sponsor: King Saud University | Conditions: Diabetes Type 2, Osteoporosis | Phase 4 | Status: NOT_YET_RECRUITING